Shuang Zhang

Comparison of Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement and Lipid-Lowering Therapy in the Patients With Coronary Artery Disease With Different Renal Functions

K. Dou, N. Wu, Jian‐Jun Li, 2022, Frontiers in Cardiovascular Medicine.

The Prognostic Value of Cardiac Troponin I in Patients with or without Three-Vessel Disease Undergoing Complete Percutaneous Coronary Intervention

K. Dou, N. Wu, Jian‐Jun Li, 2022, Journal of clinical medicine.

Conjoint analysis for hepatic carcinoma with hub genes and multi-slice spiral CT

Ruiqiang Xin, Ruchen Peng, X-Y Shen, 2020, Medicine.

LDL‐C rebound after long‐term evolocumab treatment and intravascular imaging evidence in a familial hypercholesterolemia patient with early‐onset myocardial infarction

Wenjia Zhang, Shuang Zhang, Naqiong Wu, 2023, Chronic Diseases and Translational Medicine.

The Effects of Sacubitril/Valsartan Compared to Olmesartan on the Blood Pressure and Glucolipid Metabolism in DM Patients with Primary Hypertension.

Shuang Zhang, Zhi-fan Li, Wen-Jia Zhang, 2023, Cardiovascular drugs and therapy.

The effect of lipid-lowering therapy on lipid-related residual risk factors: a prospective study

Wenjia Zhang, Shuang Zhang, Naqiong Wu, 2024, Lipids in health and disease.